Filings & corporate actions
- 6 NovresultsResults · Q2 FY27 · consolidated and standalone-1.2%NSE
- 16 OctshareholdingShareholding · 30 Sept 2026-0.7%NSE
- 11 AugdividendDividend · ₹20.00 per share+9.6%
- 10 AugresultsResults · Q1 FY27 · consolidated and standalone+9.6%NSE
- 20 JulshareholdingShareholding · 30 Jun 2026+0.4%NSE
- 15 MayresultsResults · Q4 FY26 · consolidated and standalone+15.4%NSE
- 17 AprshareholdingShareholding · 31 Mar 2026+3.6%NSE
- 28 JanresultsResults · Q3 FY26 · consolidated and standalone+6.5%NSE
- 16 JanshareholdingShareholding · 31 Dec 2025-2.8%NSE
Reaction to results · all yearsrose on day 0 in 11 of 23 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 6 Nov 2026 | -1.2% | +6.8% | — | 0.3× |
| Q1 FY27 | 10 Aug 2026 | +9.6% | +7.2% | +10.9% | 19.6× |
| Q4 FY26 | 15 May 2026 | +15.4% | +24.9% | +16.6% | 48.0× |
| Q3 FY26 | 28 Jan 2026 | +6.5% | +11.8% | +9.4% | 22.2× |
| Q2 FY26 | 3 Nov 2025 | -3.1% | -6.8% | -10.2% | 3.8× |
| Q1 FY26 | 5 Aug 2025 | -0.4% | -0.7% | -3.7% | 4.1× |
| Q4 FY25 | 20 May 2025 | +4.9% | +1.8% | +15.8% | 7.5× |
| Q3 FY25 | 3 Feb 2025 | -3.7% | -4.1% | +4.1% | 3.8× |
| Q2 FY25 | 4 Nov 2024 | +13.8% | +9.5% | +13.9% | 32.7× |
| Q1 FY25 | 6 Aug 2024 | -3.8% | -7.1% | -10.2% | 5.1× |
| Q4 FY24 | 22 May 2024 | +5.0% | +3.2% | +1.3% | 11.6× |
| Q3 FY24 | 14 Feb 2024 | -2.7% | -2.6% | -10.3% | 5.5× |
| Q2 FY24 | 6 Nov 2023 | +5.0% | +3.2% | +12.3% | 6.3× |
| Q1 FY24 | 7 Aug 2023 | +20.0% | +15.2% | +26.0% | 7.4× |
| Q4 FY23 | 19 May 2023 | -20.0% | -30.2% | -24.2% | 4.7× |
| Q3 FY23 | 23 Jan 2023 | -1.5% | -8.2% | -3.6% | 4.7× |
| Q2 FY23 | 26 Oct 2022 | -14.6% | -17.1% | -23.9% | 15.3× |
| Q4 FY22 | 20 May 2022 | -1.1% | -6.2% | -17.2% | 0.8× |
| Q3 FY22 | 21 Jan 2022 | -7.4% | -1.5% | -9.0% | 3.0× |
| Q2 FY22 | 22 Oct 2021 | +0.9% | -0.3% | -5.0% | 6.5× |
| Q1 FY22 | 21 Jul 2021 | +9.3% | +5.4% | +4.3% | 7.5× |
| Q4 FY21 | 18 May 2021 | +9.6% | +17.2% | +12.6% | 4.3× |
| Q3 FY21 | 22 Jan 2021 | -1.5% | -8.1% | +4.2% | 1.2× |
| Average | +1.7% | +0.6% | +0.6% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +9.6% | +18.0% | — | — | — | — |
| Profit | +33.7% | +20.9% | — | — | — | — |
Key data
Delivery percentage
Over the last 20 sessions GLAND settled 55.5% of its traded quantity, which is above average for an NSE equity. Its one-year average is 53.5%, so recent sessions are running 2.0 points higher than usual. The latest session ranks higher than 86% of the 1,483 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +1.18% | -0.07% | +16.89% | +18.15% | +42.94% | +82.07% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 1,695.4 | 1,742.8 | 1,800.3 | 1,833.6 |
| YoY chg | +22.5% | +22.3% | +19.6% | +23.3% |
| Net profit (₹ Cr) | 261.5 | 366.7 | 317.0 | 290.8 |
| YoY chg | +27.7% | +96.6% | +47.1% | +58.3% |
| Net margin | 15.4% | 21.0% | 17.6% | 15.9% |
| EPS | 15.87 | 22.23 | 19.22 | 17.62 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 45.75% · public 54.25%- Promoter
- Public and others
- Promoter
- 45.75%
- Public
- 54.25%
- Promoter change
- -6.02 pp
- Filed
- 16 Oct 2026
- FII
- 10.36%
- DII
- 33.21%
- Promoter pledged
- 0.00%
Who the public is
- Mutual funds
- 29.52%
- Insurance
- 2.43%
- FPI
- 10.36%
- Retail ≤ ₹2L
- 4.02%
- HNI > ₹2L
- 0.61%
- NRI
- 0.31%
- Bodies corporate
- 5.33%
- Shareholders
- 1,25,667
+1.29 pp QoQ
+1.15 pp QoQ
+1.62 pp QoQ
+1.13 pp QoQ
0.00 pp QoQ
+0.07 pp QoQ
+0.31 pp QoQ
+16.1% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| Fosun Pharma Industrial Pte. Ltd | Promoter · Corporate | 45.75% | 7.55Cr |
| Hdfc Mutual Fund - Hdfc Mid-Cap Fund | Mutual fund | 5.60% | 92.43L |
| Nippon Life India Trustee Ltd- A/C Nippon India Growth Mid Cap Fund | Mutual fund | 4.87% | 80.41L |
| Sbi Large & Midcap Fund | Mutual fund | 3.20% | 52.73L |
| Mirae Asset Large & Midcap Fund | Mutual fund | 2.92% | 48.11L |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund | Mutual fund | 2.51% | 41.39L |
| Kotak Midcap Fund | Mutual fund | 2.42% | 39.87L |
| Dsp Small Cap Fund | Mutual fund | 1.57% | 25.98L |
| Hdfc Life Insurance Company Limited | Insurance | 1.51% | 24.87L |
| Icici Prudential India Opportunities Fund | Mutual fund | 1.41% | 23.33L |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹20.00 | ₹20.00 |
| FY2025-26 | 1 | ₹18.00 | ₹18.00 |
| FY2024-25 | 1 | ₹20.00 | ₹20.00 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 11 Aug 2026 | — | ₹20.00 | ₹20.00 |
| 14 Aug 2025 | — | ₹18.00 | ₹18.00 |
| 16 Aug 2024 | — | ₹20.00 | ₹20.00 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Book closures & record dates
NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- none on record
- Disclosures on record
- 475
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 4 Jun 2026 | Jayatheerth AdvaniEmployee | Sell | 1.0K | ₹23.6L | 2,355.00 | 2.1K → 1.1K | 0.00%0.00 pp | 7(2)told 2 Jun 2026 |
| 28 May 2026 | K RAGHURAMACHANDRA RAOEmployee | Sell | 1.0K | ₹23.2L | 2,319.70 | 1.0K → 44 | 0.00%0.00 pp | 7(2)told 28 May 2026 |
| 28 May 2026 | K RAGHURAMACHANDRA RAOEmployee | Sell | 1.0K | ₹23.5L | 2,345.90 | 2.0K → 1.0K | 0.00%0.00 pp | 7(2)told 26 May 2026 |
| 25 May 2026 | SREENIVASA RAO SURAGAMEmployee | Sell | 500 | ₹11.5L | 2,300.00 | 1.9K → 1.4K | 0.00%0.00 pp | 7(2)told 22 May 2026 |
| 25 May 2026 | Jayatheerth AdvaniEmployee | Sell | 500 | ₹11.8L | 2,355.00 | 2.6K → 2.1K | 0.00%0.00 pp | 7(2)told 22 May 2026 |
| 21 May 2026 | SREENIVASA RAO SURAGAMEmployee | Sell | 1.0K | ₹21.7L | 2,170.00 | 2.9K → 1.9K | 0.00%0.00 pp | 7(2)told 19 May 2026 |
| 21 May 2026 | Jayatheerth AdvaniEmployee | Sell | 1.0K | ₹22.4L | 2,235.00 | 3.6K → 2.6K | 0.00%0.00 pp | 7(2)told 20 May 2026 |
| 21 May 2026 | Jayatheerth AdvaniEmployee | Sell | 346 | ₹7.7L | 2,238.00 | 3.9K → 3.6K | 0.00%0.00 pp | 7(2)told 20 May 2026 |
| 11 Feb 2026 | A. JAYATHEERTHAEmployee | Sell | 100 | ₹1.9L | 1,888.00 | 4.0K → 3.9K | 0.00%0.00 pp | 7(2)told 9 Feb 2026 |
| 5 Feb 2026 | A. JAYATHEERTHAEmployee | Sell | 306 | ₹5.9L | 1,922.00 | 4.3K → 4.0K | 0.00%0.00 pp | 7(2)told 3 Feb 2026 |
| 5 Feb 2026 | P LAKSHMI NARAYANAEmployee | Sell | 800 | ₹14.9L | 1,861.00 | 800 → — | 0.00% | 7(2)told 3 Feb 2026 |
| 25 Nov 2025 | P LAKSHMI NARAYANAEmployee | Sell | 300 | ₹5.4L | 1,802.82 | 1.1K → 800 | 0.00%0.00 pp | 7(2)told 24 Nov 2025 |
| 29 Sept 2025 | A. JAYATHEERTHAEmployee | Sell | 191 | ₹3.8L | 1,988.90 | 4.5K → 4.3K | 0.00%0.00 pp | 7(2)told 29 Sept 2025 |
| 29 Sept 2025 | A. JAYATHEERTHAEmployee | Sell | 325 | ₹6.6L | 2,038.00 | 4.8K → 4.5K | 0.00%0.00 pp | 7(2)told 25 Sept 2025 |
| 28 Jun 2024 | BH LENIN KUMAR RAJAEmployee | Sell | 1.4K | ₹25.3L | 1,807.86 | 1.5K → 100 | 0.00%0.00 pp | 7(2)told 28 Jun 2024 |
| 28 Jun 2024 | RONG WUEmployee | Sell | 5.8K | ₹1.0Cr | 1,788.77 | 5.8K → 26 | 0.00%0.00 pp | 7(2)told 28 Jun 2024 |
| 28 Jun 2024 | S SRINIVASA RAOEmployee | Sell | 1.9K | ₹35.3L | 1,812.28 | 2.0K → 50 | 0.00%0.00 pp | 7(2)told 28 Jun 2024 |
| 28 Jun 2024 | P B Ravindra VarmaEmployee | Sell | 1.9K | ₹35.3L | 1,810.00 | 2.0K → 50 | 0.00%0.00 pp | 7(2)told 28 Jun 2024 |
| 28 Jun 2024 | RONG WUEmployee | Sell | 6.2K | ₹1.1Cr | 1,820.25 | 12.0K → 5.8K | 0.00%0.00 pp | 7(2)told 26 Jun 2024 |
| 28 Jun 2024 | S SRINIVASA RAOEmployee | Sell | 1.0K | ₹18.2L | 1,822.00 | 3.0K → 2.0K | 0.00%0.00 pp | 7(2)told 26 Jun 2024 |
| 28 Jun 2024 | P B Ravindra VarmaEmployee | Sell | 2.0K | ₹36.5L | 1,824.92 | 4.0K → 2.0K | 0.00%0.00 pp | 7(2)told 26 Jun 2024 |
| 26 Jun 2024 | A. JAYATHEERTHAEmployee | Sell | 968 | ₹17.7L | 1,825.00 | 5.8K → 4.8K | 0.00%0.00 pp | 7(2)told 26 Jun 2024 |
| 26 Jun 2024 | K. RAGHURAMACHANDRA RAOEmployee | Sell | 1.5K | ₹27.4L | 1,825.00 | 3.5K → 2.0K | 0.00%0.00 pp | 7(2)told 25 Jun 2024 |
| 26 Jun 2024 | S SRINIVASA RAOEmployee | Sell | 1.0K | ₹18.3L | 1,825.00 | 4.0K → 3.0K | 0.00%0.00 pp | 7(2)told 25 Jun 2024 |
| 26 Jun 2024 | P B Ravindra VarmaEmployee | Sell | 4.0K | ₹73.0L | 1,825.00 | 8.0K → 4.0K | 0.00%0.00 pp | 7(2)told 25 Jun 2024 |
| 26 Jun 2024 | T.V. SATYANARAYANAEmployee | Sell | 2.3K | ₹41.0L | 1,822.44 | 2.3K → 50 | 0.00%0.00 pp | 7(2)told 25 Jun 2024 |
| 26 Jun 2024 | PRAKASH BALIGAEmployee | Sell | 500 | ₹9.1L | 1,817.06 | 514 → 14 | 0.00%0.00 pp | 7(2)told 25 Jun 2024 |
| 26 Jun 2024 | BH LENIN KUMAR RAJAEmployee | Sell | 3.0K | ₹54.7L | 1,824.00 | 4.5K → 1.5K | 0.00%0.00 pp | 7(2)told 25 Jun 2024 |
| 21 Jun 2024 | FOSUN PHARMA INDUSTRIAL PTE. LTDPromoter | Sell | 99.00L | ₹1,754.1Cr | 1,771.81 | 9.53Cr → 8.54Cr | 51.83%-6.01 pp | 7(2)told 20 Jun 2024 |
| 21 Jun 2024 | PRAKASH BALIGAEmployee | Sell | 13.0K | ₹2.4Cr | 1,825.34 | 13.5K → 514 | 0.00%0.00 pp | 7(2)told 21 Jun 2024 |
| 12 Jun 2024 | K. RAGHURAMACHANDRA RAOEmployee | Sell | 1.5K | ₹27.5L | 1,890.00 | 5.0K → 3.5K | 0.00%0.00 pp | 7(2)told 11 Jun 2024 |
| 12 Jun 2024 | K. RAGHURAMACHANDRA RAOEmployee | Sell | 3.0K | ₹55.5L | 1,850.00 | 8.0K → 5.0K | 0.00%0.00 pp | 7(2)told 10 Jun 2024 |
| 7 Jun 2024 | K. RAGHURAMACHANDRA RAOEmployee | Sell | 1.0K | ₹18.5L | 1,850.25 | 9.0K → 8.0K | 0.00%0.00 pp | 7(2)told 5 Jun 2024 |
| 4 Jun 2024 | M N RAVI CHANDRAEmployee | Sell | 4.0K | ₹73.6L | 1,840.15 | 4.0K → — | 0.00% | 7(2)told 31 May 2024 |
| 4 Jun 2024 | M N RAVI CHANDRAEmployee | Sell | 1.0K | ₹18.4L | 1,839.15 | 5.0K → 4.0K | 0.00%0.00 pp | 7(2)told 31 May 2024 |
| 4 Jun 2024 | Dr.C.S. VENKATESANEmployee | Sell | 5.0K | ₹91.9L | 1,837.25 | 5.0K → — | 0.00% | 7(2)told 31 May 2024 |
| 27 Mar 2024 | CH JYOTHIRLATHAEmployee | Sell | 2.5K | ₹44.6L | 1,757.12 | 2.5K → — | 0.00% | 7(2)told 24 Mar 2024 |
| 22 Mar 2024 | P BALAJIEmployee | Sell | 700 | ₹12.5L | 1,786.57 | 1.2K → 467 | 0.00%0.00 pp | 7(2)told 20 Mar 2024 |
| 18 Mar 2024 | K.V.G.K.RAJUKMP | Sell | 8.0K | ₹1.4Cr | 1,790.94 | 8.0K → — | 0.00% | 7(2)told 16 Mar 2024 |
| 18 Mar 2024 | P BALAJIEmployee | Sell | 500 | ₹8.9L | 1,781.01 | 1.7K → 1.2K | 0.00%0.00 pp | 7(2)told 18 Mar 2024 |
| 18 Mar 2024 | P BALAJIEmployee | Sell | 500 | ₹8.7L | 1,747.00 | 2.2K → 1.7K | 0.00%0.00 pp | 7(2)told 15 Mar 2024 |
| 14 Mar 2024 | M N RAVI CHANDRAEmployee | Sell | 5.0K | ₹86.5L | 1,730.00 | 10.0K → 5.0K | 0.00%0.00 pp | 7(2)told 13 Mar 2024 |
| 29 Feb 2024 | PRAKASH BALIGAEmployee | Sell | 1.5K | ₹28.1L | 1,844.67 | 1.5K → 14 | 0.00%0.00 pp | 7(2)told 27 Feb 2024 |
| 31 Dec 2023 | K. RAGHURAMACHANDRA RAOOther | Sell | 3.0K | ₹57.7L | 1,923.33 | 7.6K → 4.6K | 0.00%0.00 pp | 7(2)told 28 Dec 2023 |
| 31 Dec 2023 | SUBBA RAJU M VOther | Sell | 1.7K | ₹32.9L | 1,938.00 | 4.7K → 3.0K | 0.00%0.00 pp | 7(2)told 29 Dec 2023 |
| 27 Dec 2023 | K. RAGHURAMACHANDRA RAOOther | Sell | 2.0K | ₹37.9L | 1,897.00 | 9.6K → 7.6K | 0.00%0.00 pp | 7(2)told 27 Dec 2023 |
| 27 Dec 2023 | Dr.C.S. VENKATESANKMP | Sell | 1.8K | ₹33.7L | 1,872.49 | 6.8K → 5.0K | 0.00%0.00 pp | 7(2)told 23 Dec 2023 |
| 27 Dec 2023 | Dr.C.S. VENKATESANKMP | Sell | 3.2K | ₹60.2L | 1,881.55 | 10.0K → 6.8K | 0.00%0.00 pp | 7(2)told 23 Dec 2023 |
| 20 Dec 2023 | P B Ravindra VarmaOther | Sell | 9.0K | ₹1.7Cr | 1,845.01 | 9.0K → — | 0.00% | 7(2)told 20 Dec 2023 |
| 20 Dec 2023 | T.V. SATYANARAYANAOther | Sell | 1.1K | ₹20.2L | 1,840.00 | 1.1K → — | 0.00% | 7(2)told 19 Dec 2023 |
| 18 Dec 2023 | CH JYOTHIRLATHAOther | Sell | 2.0K | ₹35.9L | 1,795.00 | 4.5K → 2.5K | 0.00%0.00 pp | 7(2)told 15 Dec 2023 |
| 18 Dec 2023 | S SRINIVASA RAOOther | Sell | 4.0K | ₹72.7L | 1,817.60 | 8.0K → 4.0K | 0.00%0.00 pp | 7(2)told 15 Dec 2023 |
| 18 Dec 2023 | K.V.G.K.RAJUKMP | Sell | 10.0K | ₹1.8Cr | 1,801.52 | 18.0K → 8.0K | 0.00%0.00 pp | 7(2)told 15 Dec 2023 |
| 18 Dec 2023 | K. RAGHURAMACHANDRA RAOOther | Sell | 2.0K | ₹36.4L | 1,820.00 | 11.6K → 9.6K | 0.01%-0.00 pp | 7(2)told 15 Dec 2023 |
| 13 Dec 2023 | K. RAGHURAMACHANDRA RAOOther | Sell | 3.0K | ₹54.9L | 1,828.05 | 14.6K → 11.6K | 0.01%-0.00 pp | 7(2)told 13 Dec 2023 |
| 13 Dec 2023 | K.V.G.K.RAJUKMP | Sell | 15.0K | ₹2.7Cr | 1,800.30 | 33.0K → 18.0K | 0.01%-0.01 pp | 7(2)told 13 Dec 2023 |
| 12 Dec 2023 | A. JAYATHEERTHAOther | Sell | 2.0K | ₹36.0L | 1,798.00 | 7.8K → 5.8K | 0.00%0.00 pp | 7(2)told 12 Dec 2023 |
| 12 Dec 2023 | K. RAGHURAMACHANDRA RAOOther | Sell | 4.5K | ₹81.2L | 1,805.00 | 19.1K → 14.6K | 0.01%-0.00 pp | 7(2)told 12 Dec 2023 |
| 11 Dec 2023 | K. RAGHURAMACHANDRA RAOOther | Sell | 495 | ₹8.8L | 1,785.00 | 19.6K → 19.1K | 0.01%-0.00 pp | 7(2)told 9 Dec 2023 |
| 11 Dec 2023 | K. RAGHURAMACHANDRA RAOOther | Sell | 3.0K | ₹54.3L | 1,808.55 | 22.6K → 19.6K | 0.01%-0.00 pp | 7(2)told 7 Dec 2023 |
| 1 Dec 2023 | K.V.G.K.RAJUKMP | Sell | 15.0K | ₹2.7Cr | 1,781.95 | 48.0K → 33.0K | 0.02%-0.01 pp | 7(2)told 29 Nov 2023 |
| 29 Nov 2023 | P B RAVINDRA VARMAOther | Sell | 8.0K | ₹1.4Cr | 1,747.52 | 17.5K → 9.5K | 0.01%-0.01 pp | 7(2)told 28 Nov 2023 |
| 8 Sept 2023 | K V G K RAJUKMP | Sell | 6.0K | ₹1.0Cr | 1,734.09 | 53.9K → 48.0K | 0.03%-0.00 pp | 7(2)told 6 Sept 2023 |
| 8 Sept 2023 | K V G K RAJUKMP | Sell | 44 | ₹76,611 | 1,741.16 | 54.0K → 53.9K | 0.03%-0.00 pp | 7(2)told 6 Sept 2023 |
| 3 Mar 2023 | PRAKASH BALIGAKMP | Sell | 1.0K | ₹13.3L | 1,315.99 | 2.5K → 1.5K | 0.00%0.00 pp | 7(2)told 3 Mar 2023 |
| 20 Feb 2023 | PRAKASH BALIGAKMP | Sell | 1.7K | ₹23.5L | 1,364.34 | 4.3K → 2.5K | 0.00%0.00 pp | 7(2)told 17 Feb 2023 |
| 16 Feb 2023 | PRAKASH BALIGAKMP | Sell | 500 | ₹6.8L | 1,365.54 | 4.8K → 4.3K | 0.00%0.00 pp | 7(2)told 15 Feb 2023 |
| 9 Feb 2023 | A JAYATHEERTHAOther | Sell | 500 | ₹6.3L | 1,265.00 | 8.3K → 7.8K | 0.00%0.00 pp | 7(2)told 9 Feb 2023 |
| 7 Feb 2023 | A JAYATHEERTHAOther | Sell | 500 | ₹6.2L | 1,245.00 | 8.8K → 8.3K | 0.01%-0.00 pp | 7(2)told 6 Feb 2023 |
| 7 Feb 2023 | VANI SANAKAOther | Sell | 600 | ₹7.6L | 1,260.52 | 600 → — | 0.00% | 7(2)told 3 Feb 2023 |
| 29 Dec 2022 | A JAYATHEERTHAOther | Sell | 500 | ₹8.0L | 1,595.00 | 9.3K → 8.8K | 0.01%-0.00 pp | 7(2)told 28 Dec 2022 |
| 14 Dec 2022 | A JAYATHEERTHAOther | Sell | 200 | ₹3.5L | 1,731.00 | 9.5K → 9.3K | 0.01%-0.00 pp | 7(2)told 12 Dec 2022 |
| 14 Dec 2022 | VANI SANAKAOther | Sell | 600 | ₹10.4L | 1,725.00 | 1.2K → 600 | 0.00%0.00 pp | 7(2)told 12 Dec 2022 |
| 9 Dec 2022 | ROOPAK BHARTEEOther | Sell | 500 | ₹8.7L | 1,737.77 | 500 → — | 0.00% | 7(2)told 7 Dec 2022 |
| 28 Sept 2022 | SUBBA RAJU M VOther | Sell | 2.0K | ₹41.3L | 2,065.00 | 2.0K → — | 0.00% | 7(2)told 27 Sept 2022 |
| 28 Sept 2022 | VANI SANAKAOther | Sell | 1.5K | ₹30.9L | 2,059.95 | 2.7K → 1.2K | 0.00%0.00 pp | 7(2)told 28 Sept 2022 |
| 20 Sept 2022 | P BALAJIOther | Sell | 1.0K | ₹23.2L | 2,320.00 | 3.2K → 2.2K | 0.00%0.00 pp | 7(2)told 16 Sept 2022 |
| 17 Aug 2022 | P BALAJIOther | Sell | 500 | ₹11.7L | 2,340.00 | 3.7K → 3.2K | 0.00%0.00 pp | 7(2)told 12 Aug 2022 |
| 17 Aug 2022 | P JITENDER REDDYOther | Sell | 684 | ₹16.0L | 2,342.19 | 884 → 200 | 0.00%0.00 pp | 7(2)told 13 Aug 2022 |
| 10 Aug 2022 | P BALAJIOther | Sell | 500 | ₹11.6L | 2,320.00 | 4.2K → 3.7K | 0.00%0.00 pp | 7(2)told 9 Aug 2022 |
| 10 Aug 2022 | P JITENDER REDDYOther | Sell | 116 | ₹2.7L | 2,331.00 | 1.0K → 884 | 0.00%0.00 pp | 7(2)told 10 Aug 2022 |
| 10 Aug 2022 | P JITENDER REDDYOther | Sell | 500 | ₹11.6L | 2,325.00 | 1.5K → 1.0K | 0.00%0.00 pp | 7(2)told 8 Aug 2022 |
| 3 Aug 2022 | VANI SANAKAOther | Sell | 400 | ₹9.0L | 2,250.00 | 3.1K → 2.7K | 0.00%0.00 pp | 7(2)told 1 Aug 2022 |
| 2 Aug 2022 | SUBBA RAJU M VOther | Sell | 1.0K | ₹22.5L | 2,250.05 | 3.0K → 2.0K | 0.00%0.00 pp | 7(2)told 29 Jul 2022 |
| 2 Aug 2022 | A JAYATHEERTHAOther | Sell | 500 | ₹11.2L | 2,243.09 | 10.2K → 9.7K | 0.01%-0.00 pp | 7(2)told 29 Jul 2022 |
| 2 Aug 2022 | P JITENDER REDDYOther | Sell | 500 | ₹11.5L | 2,290.00 | 2.0K → 1.5K | 0.00%0.00 pp | 7(2)told 29 Jul 2022 |
| 4 Jul 2022 | S SURESHOther | Sell | 400 | ₹10.8L | 2,710.00 | 600 → 200 | 0.00%0.00 pp | 7(2)told 3 Jul 2022 |
| 4 Jul 2022 | P JITENDER REDDYOther | Sell | 200 | ₹5.4L | 2,680.00 | 2.2K → 2.0K | 0.00%0.00 pp | 7(2)told 1 Jul 2022 |
| 4 Jul 2022 | S SRINIVASA RAOOther | Sell | 1.5K | ₹40.4L | 2,694.04 | 9.5K → 8.0K | 0.00%0.00 pp | 7(2)told 1 Jul 2022 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Filings
CSVBulk & block deals · 17 Sept 2026
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 17 Sept 2026 | Buy · block | BOFA SECURITIES EUROPE SA | 1.50L | 2,826.60 | ₹42.4Cr |
| 17 Sept 2026 | Sell · block | NORTH ROCK SG VCC | 1.50L | 2,826.60 | ₹42.4Cr |
| 21 Mar 2025 | Buy · bulk | VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | 10.16L | 1,588.69 | ₹161.4Cr |
| 21 Mar 2025 | Buy · bulk | VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIF | 8.39L | 1,588.69 | ₹133.2Cr |
| 9 Apr 2024 | Sell · bulk | LAKUMI TRUST | 61.65L | 1,739.10 | ₹1,072.2Cr |
| 9 Apr 2024 | Sell · bulk | NICOMAC MACHINERY PRIVATE LIMITED | 19.55L | 1,735.31 | ₹339.3Cr |
| 9 Aug 2023 | Sell · bulk | GRAVITON RESEARCH CAPITAL LLP | 11.10L | 1,700.02 | ₹188.8Cr |
| 9 Aug 2023 | Buy · bulk | GRAVITON RESEARCH CAPITAL LLP | 11.10L | 1,698.72 | ₹188.6Cr |
| 22 May 2023 | Sell · bulk | MORGAN STANLEY INVESTMENT FUNDS EMERGING MARKETS EQUITY FUND | 9.60L | 930.69 | ₹89.4Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
No surveillance measure applies to GLAND.
Price band: 20% · not in the F&O ban.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.
Every stock on this session →Financials · quarterly statement
| Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,545.2 | 1,537.5 | 1,401.7 | 1,405.8 | 1,384.1 | 1,424.9 | 1,505.6 | 1,486.9 | 1,695.4 | 1,742.8 | 1,800.3 | 1,833.6 | |
| Other income | 37.4 | 42.1 | 51.4 | 59.7 | 58.5 | 44.0 | 57.5 | 84.2 | 63.2 | 111.5 | 61.2 | 69.0 | |
| Total income | 1,582.5 | 1,579.6 | 1,453.1 | 1,465.5 | 1,442.5 | 1,468.9 | 1,563.1 | 1,571.0 | 1,758.5 | 1,854.3 | 1,861.5 | 1,902.6 | |
| Total expenses | 1,299.4 | 1,281.4 | 1,234.9 | 1,208.7 | 1,143.2 | 1,180.6 | 1,250.4 | 1,287.1 | 1,372.1 | 1,348.5 | 1,426.5 | 1,471.7 | |
| └ Finance costs | 5.3 | 10.0 | 5.6 | 6.1 | 22.8 | 7.5 | 11.5 | 7.8 | 3.9 | 10.0 | 4.4 | 7.1 | |
| └ Depreciation | 105.3 | 92.6 | 92.0 | 93.8 | 96.3 | 95.8 | 101.1 | 106.3 | 107.6 | 108.7 | 111.3 | 115.0 | |
| Profit before tax | 283.2 | 298.2 | 218.2 | 256.8 | 299.3 | 288.3 | 312.7 | 283.9 | 362.1 | 505.8 | 435.0 | 430.9 | |
| Tax expense | 91.3 | 105.8 | 74.5 | 93.2 | 94.6 | 101.8 | 97.3 | 100.2 | 100.7 | 139.1 | 118.0 | 140.2 | |
| Net profit | 191.9 | 192.4 | 143.8 | 163.5 | 204.7 | 186.5 | 215.5 | 183.7 | 261.5 | 366.7 | 317.0 | 290.8 | |
| EPS | 11.65 | 11.68 | 8.73 | 9.93 | 12.42 | 11.32 | 13.08 | 11.15 | 15.87 | 22.26 | 19.23 | 17.62 | |
| Net margin | 12.42% | 12.52% | 10.26% | 11.63% | 14.79% | 13.09% | 14.31% | 12.35% | 15.42% | 21.04% | 17.61% | 15.86% | |
| PBT margin | 18.33% | 19.40% | 15.57% | 18.27% | 21.63% | 20.24% | 20.77% | 19.09% | 21.36% | 29.02% | 24.16% | 23.50% | |
| Tax rate | 32.24% | 35.48% | 34.13% | 36.31% | 31.61% | 35.30% | 31.10% | 35.30% | 27.79% | 27.51% | 27.13% | 32.53% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 6 Nov 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8,777.5 | 10,292.8 | 10,661.2 | 10,866.9 | 11,224.9 | 11,799.9 | 12,510.8 | 12,926.7 | |
| Current assets | 6,900.8 | 5,971.3 | 5,645.2 | 6,404.1 | 6,782.9 | 7,045.3 | 7,526.8 | 7,872.3 | |
| └ Cash & equivalents | 1,908.9 | 480.8 | 357.1 | 2,820.1 | 2,556.2 | 2,703.9 | 3,359.1 | 3,441.2 | |
| └ Other bank balances | 1,861.8 | 1,663.9 | 1,482.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Current investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Trade receivables | 871.4 | 1,373.1 | 1,558.7 | 1,490.0 | 1,516.5 | 1,564.7 | 1,891.4 | 1,927.4 | |
| └ Inventories | 1,945.3 | 2,084.3 | 1,655.2 | 1,577.0 | 1,685.2 | 1,813.6 | 1,743.9 | 1,828.6 | |
| Total equity | 7,958.7 | 8,306.7 | 8,723.8 | 8,788.0 | 9,150.7 | 9,562.6 | 10,358.0 | 10,685.7 | |
| └ Attributable to owners | 7,958.7 | 8,306.7 | 8,723.8 | 8,788.0 | 9,150.7 | 9,562.6 | 10,358.0 | 10,685.7 | |
| └ Non-controlling interest | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| └ Share capital | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 | 16.5 | |
| Borrowings | 3.8 | 312.7 | 319.8 | 278.8 | 269.2 | 255.5 | 243.4 | 219.6 | |
| └ Current | 0.6 | 192.1 | 213.2 | 185.2 | 191.6 | 181.4 | 173.4 | 156.2 | |
| └ Non-current | 3.3 | 120.6 | 106.5 | 93.6 | 77.7 | 74.2 | 69.9 | 63.4 | |
| Trade payables | 587.4 | 978.2 | 862.7 | 997.7 | 820.4 | 923.6 | 833.9 | 938.2 | |
| Current liabilities | 729.1 | 1,536.2 | 1,398.4 | 1,538.8 | 1,564.8 | 1,706.1 | 1,608.4 | 1,714.0 | |
| Total liabilities | 818.8 | 1,986.1 | 1,937.4 | 2,078.9 | 2,074.2 | 2,237.3 | 2,152.9 | 2,241.1 | |
| Net debt | (3,766.9) | (1,832.0) | (1,519.7) | (2,541.3) | (2,287.0) | (2,448.4) | (3,115.7) | (3,221.6) | |
| Debt / equity | 0.00 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | |
| Current ratio | 9.46 | 3.89 | 4.04 | 4.16 | 4.33 | 4.13 | 4.68 | 4.59 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 364.0 | 421.8 | 996.8 | 643.6 | 914.7 | 593.3 | 1,031.4 | 602.7 | |
| └ Capex | (223.1) | (166.4) | (398.3) | (167.4) | (394.2) | (197.0) | (494.4) | (257.1) | |
| Free cash flow | 140.8 | 255.3 | 598.5 | 476.2 | 520.6 | 396.2 | 537.0 | 345.7 | |
| Investing cash flow | 1,208.2 | (1,049.8) | (1,756.9) | 2,212.6 | 1,704.7 | (92.4) | 137.7 | (188.3) | |
| Financing cash flow | 14.9 | (801.0) | (799.4) | (402.7) | (433.5) | (378.8) | (417.0) | (360.0) | |
| └ Dividends paid | 0.0 | 0.0 | 0.0 | (329.5) | (329.5) | (296.5) | (296.6) | (329.9) | |
| └ Buybacks | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | 1,590.1 | (1,428.1) | (1,551.8) | 2,463.0 | 2,199.1 | 122.1 | 752.1 | 54.4 |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →GLAND at a glance
- GLAND closed at ₹3,331.9 on 20 Nov 2026, +1.18% on the day, +82.1% over one year, 2.8% below its 52-week high of ₹3,429.
- Delivery was 70.9% of traded quantity on 20 Nov 2026, the 86th percentile of its own 1,483 sessions with a reading (20-session average 55.5%, 1-year average 53.5%).
- Market capitalisation is ₹54,980 crore at a trailing P/E of 44.5 (trailing EPS ₹74.9).
- Q2 FY27 results (consolidated, filed 6 Nov 2026): revenue ₹1,834 crore (+23.3% year on year), net profit ₹291 crore (+58.3%); the price moved -1.2% on the first session after.
- Promoters held 45.75% at 30 Sept 2026, down 6.02 percentage points on the previous filing.
- Q3 FY27 results are expected between 21 Jan 2027 and 14 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Sector history
- to 16 Aug 2026Index industry · Healthcare
- from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
NSE’s own classification, by the snapshot it changed on.
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,180.50+0.02%
- LALAURUSLABSLaurus Labs Limited2,294.60-0.49%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,884.90-0.79%
- ACACUTAASAcutaas Chemicals Limited3,833.50-3.61%
- SASAILIFESai Life Sciences Limited1,800.70+0.69%
- PPPPLPHARMAPiramal Pharma Limited239.30-0.15%
- DRDRREDDYDr. Reddy's Laboratories Limited1,390.20-0.76%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,648.00+1.51%
- AUAUROPHARMAAurobindo Pharma Limited1,799.00-0.37%
- CICIPLACipla Limited1,415.00-0.25%
- ZYZYDUSLIFEZydus Lifesciences Limited1,200.00-0.24%
- MAMANKINDMankind Pharma Limited2,665.00+1.37%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE